EUVIMEDEUVIMED entdecken
Crossref

Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety

Takae Okuno, Masafumi Hongoh, Ryosuke Tanino, Tamio Okimoto, Yukari Tsubata, Takeshi Isobe

Anticancer Research · 2025

DOI: 10.21873/anticanres.17627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Takae Okuno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University Faculty of Medicine, Shimane, Japan. Hauptthemen laut MEDLINE: Acrylamides, Aniline Compounds, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcrylamidesAniline CompoundsLung NeoplasmsCarcinoma, Non-Small-Cell LungProtein Kinase InhibitorsAntineoplastic AgentsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesErbB ReceptorsAged, 80 and overAdultTreatment OutcomeProgression-Free SurvivalMutationPrognosisIndolesPyrimidines

Stichwörter der Autor:innen

AZ5104AZ7550NSCLCOsimertinibadverse eventsblood concentrationefficacyhematological toxicity

Substanzen

osimertinibAcrylamidesAniline CompoundsProtein Kinase InhibitorsErbB ReceptorsAntineoplastic AgentsEGFR protein, humanIndolesPyrimidines

Autor:innen und Institutionen

  • Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University Faculty of Medicine, Shimane, Japan.
  • Department of Pharmacy, Shimane University Hospital, Shimane, Japan.
  • Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University Faculty of Medicine, Shimane, Japan; okimoto@med.shimane-u.ac.jp.

Zitieren

APA

Okuno, T., Hongoh, M., Tanino, R., Okimoto, T., Tsubata, Y., & Isobe, T. (2025). Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety. Anticancer Research. https://doi.org/10.21873/anticanres.17627

Vancouver

Okuno T, Hongoh M, Tanino R, Okimoto T, Tsubata Y, Isobe T. Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety. Anticancer Research. 2025. doi:10.21873/anticanres.17627

BibTeX
@article{Okuno2025,
  author = {Okuno, Takae and Hongoh, Masafumi and Tanino, Ryosuke and Okimoto, Tamio and Tsubata, Yukari and Isobe, Takeshi},
  title = {Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17627}
}
Kostenlos starten →